UNITED THERAPEUTICS Corp 4

Director Judy D. Olian received 1,310 shares of United Therapeutics common stock upon vesting of restricted stock units, increasing her direct holdings to 5,555 shares.

On July 9, 2026, Judy D. Olian, a director of United Therapeutics Corporation, acquired 1,310 shares of common stock upon the vesting and settlement of previously granted restricted stock units, which converted on a one-for-one basis into common shares at no exercise price. The transaction was coded as an exempt, non-open-market transaction (Code M) with a price of $0.00 per share, reflecting routine equity compensation vesting rather than a discretionary purchase in the open market. Following this award, Olian directly holds 5,555 shares of United Therapeutics common stock, representing her updated beneficial ownership after the RSU vesting.

Filing Facts

CIK

1082554

Ticker

UTHR

Form

4

Source Type

fda

Accession

0001605729-26-000012

Alert Tier

5